Literature DB >> 6449331

Plaque-forming cells in human cord blood: studies on T and B cell function.

M Eibl, C C Zielinski, R Ahmad, F Steurer, A Rockenschaub.   

Abstract

Fewer plaque-forming cells (PFC) were found in the cord blood than in adult blood. B cells of newborns seem to be functionally mature. T cells of newborns provide enough help but exert increased suppressor activity.

Entities:  

Mesh：

Year:  1980        PMID： 6449331      PMCID： PMC1536907     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  11 in total

1.  Thymus-derived peripheral lymphocytes from human newborns inhibit division of their mothers' lymphocytes.

Authors:  L B Olding; B A Oldstone
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

2.  Induction of plasma cell differentiation of human fetal lymphocytes: evidence for functional immaturity of T and B cells.

Authors:  A R Hayward; A R Lawton
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

3.  Activation of human B lymphocytes. VI. Immunoregulation of antibody production by mitogen-induced and naturally occurring cells in normal individuals.

Authors:  B F Haynes; A S Fauci
Journal:  Cell Immunol       Date:  1978-03-15       Impact factor: 4.868

4.  The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.

Authors:  U Galili; M Schlesinger
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

5.  Studies on interaction of bacteria, serum factors and polymorphonuclear leukocytes in mothers and newborns.

Authors:  J H Dossett; R C Williams; P G Quie
Journal:  Pediatrics       Date:  1969-07       Impact factor: 7.124

6.  Interaction of maternal and neonatal cells in mixed-lymphocyte cultures.

Authors:  S D Lawler; E O Ukaejiofo; B R Reeves
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

7.  Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes.

Authors:  G D Ross; E M Rabellino; M J Polley; H M Grey
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

8.  Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes.

Authors:  A S Fauci; K R Pratt
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

9.  Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes.

Authors:  D E Mosier; B M Johnson
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307
View more
  5 in total

1.  Requirement for OKT8+ suppressor cell proliferation for suppression by human newborn T cells.

Authors:  A R Hayward; D Merrill
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

2.  Clinical evaluation of B cell and T-regulator cell function using a protein A haemolytic plaque assay.

Authors:  B M Jones
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

3.  Functional activity of peripheral mononuclear cells in cystic fibrosis: antibodies and plaque formation.

Authors:  M Götz; C C Zielinski; R Ahmad; M Eibl
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

4.  Macrophage-lymphocyte interaction in response to a bacterial antigen (E. coli).

Authors:  M Eibl; J W Mannhalter; R Ahmad
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

5.  Human T cell proliferation in response to E. coli presented by autologous macrophages is antigen specific.

Authors:  J W Mannhalter; G J Zlabinger; R Ahmad; M M Eibl
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.